Trial intelligence / Profile preview

Melatonin for sleep in hypertensive patients on beta-blockers

NCT00238108Phase 2Completed

Sponsor
Brigham and Women's Hospital
Start
Oct 2005
Primary completion
Aug 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in sleep disorder comparing Melatonin with Placebo (2 arms). Primary endpoint: Sleep Quality at 3 weeks. Started Oct 2005; status: completed.

02

Drugs

melatonin
03

Conditions

sleep disorder

Beyond the preview

Go deeper on NCT00238108.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00238108.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call